Court upholds Bayer patent on Ciprobay
German pharmaceuticals group Bayer AG said a US court had upheld the patent on its best-selling antibiotic Ciprobay after challenges by firms seeking to sell cheaper copycat versions. Bayer said in a
German pharmaceuticals group Bayer AG said a US court had upheld the patent on its best-selling antibiotic Ciprobay after challenges by firms seeking to sell cheaper copycat versions. Bayer said in a